Replies to post #163542 on Anavex Life Sciences Corp (AVXL)

[XenaLives]

We're talking 3.5-4 million if sold in the neighborhood of today's price. That's less than 10% dilution. If the stock is around $5 that's two million shares, under 5%.

Where do you get "massive" from?

In edit- forgot about the broker's fees, but we're still not talking "massive", are we?

The Cantor ATM is available but tapping $10+ million inside of a year to fund clinical trials doesn't seem feasible. Even if sufficient funds can be raised through Cantor, massive dilution is inevitable.

[F1ash]

The Cantor ATM is available but tapping $10+ million inside of a year to fund clinical trials doesn't seem feasible.

Easy peazy lemon squeezy.



“During the three months ended December 31, 2016, the Company issued to Lincoln Park an aggregate of 4,500,012 shares of common stock under the Purchase Agreement, including 4,472,841 shares of common stock for an aggregate purchase price of $15,128,272
and 27,171 commitment shares. At December 31, 2016, an amount of $33,513,928 in value of its shares remained available under the 2015 Purchase Agreement.


The Cantor agreement removes the $3 price floor limitations and “hard” daily limits on new share issuances.

High volume would be helpful to disguise the dilution.

[ExtremelyBullishZig]

they add up because the way we will be doing the trial will not require the same amount as the average trial costs that you supplied.